Founders & Board of directors

Yang Liu, PhD

Chairman & Founder

Dr. Liu is recognized internationally for his research on immune recognition of cancer and activation of lymphocytes, the main immune defender against cancer. He has received the Markey Scholar Award (1992), and the Sears Scholar Award (1993), and Snyder Award for Cancer Research (2015) and was elected to the rank of fellow at the American Association for Advancement of Science (AAAS) in 2004 for his pioneering contribution to Innate Immunity, T cell costimulation and cancer immunology.

Dr. Liu received his Ph.D. from the Australian National University, and postdoctoral fellowship from Yale University. Dr. Liu also has a part-time position as Director of Division of Immunotherapy, Institute of Human Virology and Professor of Surgery, University of Maryland Baltimore School of Medicine, where his laboratory studies the fundamental mechanisms of immune recognition, cell metabolism and cancer biology and has been a driving force in elucidating the mechanisms by which the innate immune system discriminates microbial infection and aseptic tissue injuries.

About Us

Based in Rockville, Maryland, OncoImmune is a
privately-held, clinical-stage biopharmaceutical
company that is actively engaged in the discovery
and development of biopharmaceuticals for the
treatment of cancer and autoimmune disease.

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.